Assessing your population’s health and evaluating interventions’ effectiveness.
Leading subject matter experts to solve your health care challenges.
Improve employee and dependent health and wellness.
Evidence-based clinical interventions for employers, systems and plans.
Accelerating innovation through collaborations with industry leaders.

News

Johns Hopkins Medicine and Walgreens Sign Collaboration Agreement

Wed, 25 May 2011

Johns Hopkins Medicine and Walgreens (the nation’s largest drugstore chain) have a wide-ranging agreement designed to promote collaboration on population-based research and to jointly review and develop protocols to improve outcomes of patients with chronic diseases. JHM and Walgreens also will together explore the development of new models for improving care for individuals. This will include the creation of new educational and training programs for Walgreens 70,000 health care service providers. The agreement provides JHM with the opportunity to develop innovative population-based research ideas with a nationwide industry leader who is committed to improving health care outcomes and possesses advanced data systems and a large patient base, prerequisites for such large-scale studies. More specifically:

  • JHM experts and the Walgreens research teams will develop new ideas for research in disease management, screening and prevention that they will spin off into proposals for funding.
  • Johns Hopkins faculty will work closely with Walgreen experts to review and improve health care protocols, medical guidelines and algorithms in the areas of chronic disease management.
  • JHM will consult on the development of a comprehensive program to expand and enhance the ongoing professional education of the professionals within the Walgreens network by leveraging the capabilities within JHM in the area of onsite and distance education for physicians, nurse practitioners, nurses, technicians, pharmacists and others.
  • JHM and Walgreens will explore the possibility of jointly developing lifestyle, chronic care and disease-specific programs.

The press release can be found here.